Explore the unprecedented outcomes from the PARTNER 3 Trial

Sign Up To View The Full NEJM Article Now

The PARTNER 3 Trial was a multicenter, randomized trial in which TAVI with transfemoral placement of a third-generation balloon-expandable valve was compared with surgical aortic-valve replacement in patients with severe aortic stenosis at low risk.

Read the peer-reviewed article for free.

heading 3

Content goes here